1. Home
  2. GABC vs FTRE Comparison

GABC vs FTRE Comparison

Compare GABC & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo German American Bancorp Inc.

GABC

German American Bancorp Inc.

HOLD

Current Price

$41.25

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$9.02

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GABC
FTRE
Founded
1910
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
GABC
FTRE
Price
$41.25
$9.02
Analyst Decision
Buy
Buy
Analyst Count
2
9
Target Price
$46.50
$15.39
AVG Volume (30 Days)
128.3K
1.4M
Earning Date
04-27-2026
05-11-2026
Dividend Yield
2.98%
N/A
EPS Growth
8.13
N/A
EPS
3.06
N/A
Revenue
$487,401,000.00
$2,723,400,000.00
Revenue This Year
$17.03
N/A
Revenue Next Year
$3.92
$3.01
P/E Ratio
$13.61
N/A
Revenue Growth
37.80
1.00
52 Week Low
$32.75
$3.97
52 Week High
$45.00
$18.67

Technical Indicators

Market Signals
Indicator
GABC
FTRE
Relative Strength Index (RSI) 51.62 35.46
Support Level $37.28 $8.85
Resistance Level $42.40 $11.22
Average True Range (ATR) 0.86 0.57
MACD 0.20 0.16
Stochastic Oscillator 72.78 26.11

Price Performance

Historical Comparison
GABC
FTRE

About GABC German American Bancorp Inc.

German American Bancorp Inc is a bank holding company. The lines of business include Retail and commercial banking business which involves attracting deposits from the general public and using those funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services which involve providing trust, investment advisory, brokerage and retirement planning services to customers. Insurance operations include the offering of a full range of personal and corporate property and casualty insurance products.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: